Senators Push OMB For Lab-Developed Test Guidance, Academic Labs Resist
This article was originally published in The Pink Sheet Daily
Executive Summary
Several Democratic Senators want the Office of Management and Budget to release the FDA draft guidance on lab-developed tests that has been stuck at OMB for years. Academic clinical labs send their own letter to the budget office, pleading that the guidance not be released.
You may also be interested in...
Regulatory Harmony Needed To Fulfill Personalized Medicine Promise
Barriers to reaching the full potential of personalized medicine diagnostics include low reimbursements, best methods to validate tests and physician education needs, as well as discordance between regulations for lab-developed tests and diagnostic test kits, witnesses told a House panel July 23.
Lawmakers Press OMB To Release Lab-Developed Test Draft Guidance
In a letter to Office of Management and Budget director Sylvia Mathews, nine Democratic representatives urged the release of a draft guidance establishing an FDA oversight structure for laboratory-developed tests. FDA said more than a year ago that the documents were under administrative review.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.